If you or someone you know is getting the Bexsero vaccine to protect against meningitis B, the official schedule for the shots has changed. The Centers for Disease Control and Prevention (CDC) has updated its recommendations to align with a new label approved by the Food and Drug Administration (FDA). This update focuses on the timing and spacing of the doses. The information provided doesn't detail what the new schedule is, who specifically it applies to, or what research led to the FDA's label change. It also doesn't report on any side effects or safety findings related to the new schedule. This announcement is about making sure medical practice follows the latest official guidance.
What changed about the meningitis B vaccine schedule?
Photo by AronPW / Unsplash
What this means for you:
CDC updates meningitis B vaccine schedule to match new FDA label. More on Meningococcal Disease
Novel Antibiotic-Resistant Neisseria meningitidis Strain Detected in the United States Health officials detect new antibiotic-resistant meningitis strain in the United States
CDC · Apr 6, 2026
Outbreak report describes meningococcal disease cases in Virginia What's happening with the meningococcal disease outbreak in Virginia?
CDC · Apr 5, 2026
CDC issues guidance on antibiotic prophylaxis for meningococcal contacts in ciprofloxacin-resistant areas How should doctors protect people exposed to drug-resistant meningitis?
CDC · Apr 5, 2026
Observational report notes increase in meningococcal disease cases among US persons with HIV in 2022 Report notes increase in meningococcal disease among people with HIV in the US
CDC · Apr 5, 2026